FR2362142B1 - - Google Patents

Info

Publication number
FR2362142B1
FR2362142B1 FR7724894A FR7724894A FR2362142B1 FR 2362142 B1 FR2362142 B1 FR 2362142B1 FR 7724894 A FR7724894 A FR 7724894A FR 7724894 A FR7724894 A FR 7724894A FR 2362142 B1 FR2362142 B1 FR 2362142B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7724894A
Other languages
French (fr)
Other versions
FR2362142A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of FR2362142A1 publication Critical patent/FR2362142A1/fr
Application granted granted Critical
Publication of FR2362142B1 publication Critical patent/FR2362142B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5456Arylalkanephosphonium compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR7724894A 1976-08-17 1977-08-12 Composes antibacteriens a cycle beta-lactame Granted FR2362142A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB34106/76A GB1531141A (en) 1976-08-17 1976-08-17 Beta-lactam antibiotics

Publications (2)

Publication Number Publication Date
FR2362142A1 FR2362142A1 (fr) 1978-03-17
FR2362142B1 true FR2362142B1 (fi) 1981-11-06

Family

ID=10361448

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7724894A Granted FR2362142A1 (fr) 1976-08-17 1977-08-12 Composes antibacteriens a cycle beta-lactame
FR7831817A Granted FR2405260A1 (fr) 1976-08-17 1978-11-10 Composes anti-bacteriens a cycle beta-lactame

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR7831817A Granted FR2405260A1 (fr) 1976-08-17 1978-11-10 Composes anti-bacteriens a cycle beta-lactame

Country Status (19)

Country Link
JP (1) JPS5323995A (fi)
AT (1) AT351678B (fi)
AU (1) AU518375B2 (fi)
BE (1) BE857781A (fi)
CA (1) CA1104139A (fi)
CH (1) CH639664A5 (fi)
DE (1) DE2736482A1 (fi)
DK (1) DK364177A (fi)
ES (1) ES461691A1 (fi)
FI (1) FI772432A (fi)
FR (2) FR2362142A1 (fi)
GB (1) GB1531141A (fi)
IE (1) IE45559B1 (fi)
IL (1) IL52638A (fi)
NL (1) NL7709007A (fi)
NZ (1) NZ184808A (fi)
PT (1) PT66882B (fi)
SE (1) SE7709071A0 (fi)
ZA (1) ZA774703B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0002564B1 (en) * 1977-11-12 1984-06-20 Beecham Group Plc Derivatives of 7-oxo-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid, their preparation, pharmaceutical compositions containing them and intermediates
EP0004132A1 (en) * 1978-03-04 1979-09-19 Beecham Group Plc Esters of beta-lactam antibiotics, a process for their preparation pharmaceutical compositions containing them and the compounds for use as antibacterial agents
US4446146A (en) * 1978-07-26 1984-05-01 Beecham Group Limited β-Lactam containing compounds, their preparation and use
DE2963580D1 (en) * 1978-08-02 1982-10-21 Beecham Group Plc Beta-lactam antibacterial agents, a process for their preparation and pharmaceutical compositions containing them
US4530791A (en) * 1979-04-16 1985-07-23 Kowa Co., Ltd. β-Lactam antibiotics
EP0024832B1 (en) * 1979-08-10 1985-03-13 Beecham Group Plc Beta-lactam antibiotics, their preparation, pharmaceutical compositions containing them and their preparation
EP0044142A1 (en) * 1980-07-03 1982-01-20 Beecham Group Plc Process for the preparation of beta-lactam antibiotics
EP0057565A1 (en) * 1981-02-04 1982-08-11 Beecham Group Plc Beta-lactam antibiotics, their preparation and use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH633554A5 (en) * 1975-11-21 1982-12-15 Merck & Co Inc Process for the preparation of novel thienamycin derivatives.

Also Published As

Publication number Publication date
ZA774703B (en) 1978-06-28
FR2362142A1 (fr) 1978-03-17
IE45559B1 (en) 1982-09-22
DK364177A (da) 1978-02-18
IL52638A0 (en) 1977-10-31
ES461691A1 (es) 1978-06-01
PT66882A (fr) 1977-09-01
ATA592177A (de) 1979-01-15
AU518375B2 (en) 1981-10-01
FR2405260A1 (fr) 1979-05-04
IL52638A (en) 1980-12-31
NL7709007A (nl) 1978-02-21
JPS5323995A (en) 1978-03-06
PT66882B (fr) 1979-01-24
FI772432A (fi) 1978-02-18
AU2798677A (en) 1979-02-22
AT351678B (de) 1979-08-10
BE857781A (fr) 1978-02-13
SE7709071L (sv) 1978-02-17
GB1531141A (en) 1978-11-01
NZ184808A (en) 1980-04-28
CA1104139A (en) 1981-06-30
SE7709071A0 (sv) 1978-02-17
IE45559L (en) 1978-02-17
DE2736482A1 (de) 1978-02-23
FR2405260B1 (fi) 1980-10-31
CH639664A5 (en) 1983-11-30

Similar Documents

Publication Publication Date Title
JPS5518213B2 (fi)
DK138564C (fi)
DK138283C (fi)
DK137650C (fi)
FR2362142B1 (fi)
DK137429C (fi)
JPS5316787U (fi)
DE2715512C3 (fi)
FR2367604B3 (fi)
JPS5385066U (fi)
DE2637745C2 (fi)
DK138293C (fi)
JPS5390516U (fi)
JPS52163754U (fi)
JPS5295938U (fi)
CH602473A5 (fi)
CH599094A5 (fi)
DD127349A1 (fi)
DD127312A6 (fi)
CH606668A5 (fi)
CH605017A5 (fi)
DD126559A1 (fi)
CH604005A5 (fi)
CH608220A5 (fi)
DD126189A1 (fi)

Legal Events

Date Code Title Description
ST Notification of lapse